|
Volumn 21, Issue 9, 2000, Pages 850-854
|
Effect of valsartan and fosinopril on catecholamine-induced cardiac hypertrophy
a a |
Author keywords
Apoptosis; Fosinopril; Hypertrophic cardiomyopathy; Norepinephnne; Valsartan
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE (CALCIUM);
ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM);
ANGIOTENSIN RECEPTOR ANTAGONIST;
CATECHOLAMINE;
COLLAGEN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FOSINOPRIL;
MYOSIN ADENOSINE TRIPHOSPHATASE;
NORADRENALIN;
VALSARTAN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
APOPTOSIS;
ARTICLE;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG SCREENING;
ENZYME ACTIVITY;
FEMALE;
HEART VENTRICLE HYPERTROPHY;
MALE;
NONHUMAN;
RAT;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANIMAL;
APOPTOSIS;
CA(2+)-TRANSPORTING ATPASE;
COLLAGEN;
FEMALE;
FOSINOPRIL;
HYPERTROPHY, LEFT VENTRICULAR;
MALE;
MYOCARDIUM;
NA(+)-K(+)-EXCHANGING ATPASE;
NOREPINEPHRINE;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, ANGIOTENSIN;
TETRAZOLES;
VALINE;
VENTRICULAR REMODELING;
|
EID: 0033795263
PISSN: 02539756
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (16)
|